Influence of the oncolytic parvovirus H-1, CTLA-4 antibody tremelimumab and cytostatic drugs on the human immune system in a human in vitro model of colorectal cancer cells

Por Heinrich, Bernd, Goepfert, Katrin, Delic, Maike, Galle, Peter R, Moehler, Markus
Publicado em 2013

Oncolytic Virotherapy as Emerging Immunotherapeutic Modality: Potential of Parvovirus H-1

Por Moehler, Markus, Goepfert, Katrin, Heinrich, Bernd, Breitbach, Caroline J., Delic, Maike, Galle, Peter Robert, Rommelaere, Jean
Publicado em 2014